Insight Molecular Diagnostics (IMDX) Shares Outstanding (2015 - 2026)

Insight Molecular Diagnostics has reported Shares Outstanding (Entity) for 12 years, with the latest figure at $32.3 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 12.89% year-over-year to $32.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.3 million (up 12.89% YoY) and the FY2025 annual result came in at $28.7 million, up 119.44% from the prior year.
• Shares Outstanding (Entity) advanced to $32.3 million in Q1 2026 per IMDX's latest filing, from $28.7 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $32.3 million in Q1 2026 and troughed at $5540.0 in Q4 2022.
• A 5-year average of $13.3 million and a median of $8.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) plunged 99.86% in 2023, then jumped 165141.04% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $5540.0 in 2022, then jumped by 149015.52% to $8.3 million in 2023, then soared by 58.23% to $13.1 million in 2024, then soared by 119.44% to $28.7 million in 2025, then grew by 12.56% to $32.3 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $32.3 million, $28.7 million, and $28.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.